cycloheximide has been researched along with Cerebral Hemorrhage in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akaike, A; Fujimoto, S; Katsuki, H; Kume, T; Ohnishi, M; Takagi, M | 1 |
Doherty, JM; Penar, PL; Shatos, MA; Sobel, BE | 1 |
2 other study(ies) available for cycloheximide and Cerebral Hemorrhage
Article | Year |
---|---|
Involvement of thrombin and mitogen-activated protein kinase pathways in hemorrhagic brain injury.
Topics: Animals; Arginine; Brain; Brain Damage, Chronic; Cell Death; Cerebral Hemorrhage; Cycloheximide; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Gliosis; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 1; MAP Kinase Signaling System; Microglia; Nerve Degeneration; Neurons; Neuroprotective Agents; Pipecolic Acids; Platelet Aggregation Inhibitors; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Sulfonamides; Thrombin | 2007 |
Suppression of plasminogen activator inhibitor-1 release from human cerebral endothelium by plasminogen activators. A factor potentially predisposing to intracranial bleeding.
Topics: Aprotinin; Cells, Cultured; Cerebral Cortex; Cerebral Hemorrhage; Cerebrovascular Circulation; Culture Techniques; Cycloheximide; Disease Susceptibility; Endothelium, Vascular; Humans; Kinetics; Meningeal Arteries; Meninges; Microcirculation; Pia Mater; Plasminogen; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Recombinant Proteins; RNA, Messenger; Streptokinase; Tissue Plasminogen Activator; Transcription, Genetic; Umbilical Veins; Urokinase-Type Plasminogen Activator | 1996 |